Published in Am J Gastroenterol on June 06, 2007
IgG4-related sclerosing disease. World J Gastroenterol (2008) 3.84
Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci (2012) 1.56
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol (2012) 1.56
Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49
IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J (2012) 1.26
IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) (2015) 1.23
Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol (2008) 1.18
Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol (2010) 1.14
Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol (2012) 1.12
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol (2014) 1.11
Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol (2010) 1.08
Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol (2009) 1.06
Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice. Int J Rheumatol (2012) 1.06
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J (2011) 1.04
Endoscopic approach for diagnosing autoimmune pancreatitis. World J Gastrointest Endosc (2010) 1.02
Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol (2010) 0.99
[IgG4-related disease]. Z Rheumatol (2013) 0.97
The Utility of Serum IgG4 Concentrations as a Biomarker. Int J Rheumatol (2012) 0.96
Pathologies Associated with Serum IgG4 Elevation. Int J Rheumatol (2012) 0.96
Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.95
Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol (2010) 0.94
IgG4 Cholangiopathy. Int J Hepatol (2011) 0.93
A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. J Gastrointest Surg (2011) 0.93
IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag (2016) 0.93
Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore) (2015) 0.87
Immunoglobulin subclass 4 for the diagnosis of immunoglobulin subclass 4-associated diseases in an unselected liver and pancreas clinic population. HPB (Oxford) (2011) 0.87
Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87
A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol (2011) 0.86
Clinical Characteristics of Patients with Autoimmune Pancreatitis with or without Mikulicz's Disease and Mikulicz's Disease Alone. Gut Liver (2012) 0.85
Immunoglobulin G4-related lung disease: a disease with many different faces. Can Respir J (2013) 0.85
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort. Am J Gastroenterol (2016) 0.84
Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids. Jpn J Ophthalmol (2014) 0.84
IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis. Dig Dis Sci (2010) 0.84
Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders. PLoS One (2015) 0.83
IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J (2014) 0.83
Poor positive predictive value of serum immunoglobulin G4 concentrations in the diagnosis of immunoglobulin G4-related sclerosing disease. Asia Pac Allergy (2014) 0.82
Diagnosis of autoimmune pancreatitis. World J Gastroenterol (2014) 0.81
IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease. Dig Dis Sci (2010) 0.81
[Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations]. Pathologe (2014) 0.81
Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. PLoS One (2013) 0.80
Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. PLoS One (2008) 0.80
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology (2016) 0.80
Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis. Sci Rep (2016) 0.79
Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis. Int J Proteomics (2012) 0.79
Cholangiocarcinoma with respect to IgG4 Reaction. Int J Hepatol (2014) 0.79
Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol (2014) 0.79
Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma. Dig Dis Sci (2014) 0.78
Diagnostic Dilemma in a Patient with Jaundice: How to Differentiate between Autoimmune Pancreatitis, Primary Sclerosing Cholangitis and Pancreas Carcinoma. Case Rep Gastroenterol (2012) 0.78
Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis. PLoS One (2016) 0.78
Comparison study of immunohistochemical staining for the diagnosis of type 1 autoimmune pancreatitis. J Gastroenterol (2014) 0.78
A Patient with Autoimmune Pancreatitis Type 1 with Previously Known Lymphadenopathy, Both in the Context of IgG4-related Disease. Am J Case Rep (2015) 0.77
Histopathological diagnostic value of the IgG4+/IgG+ ratio of plasmacytic infiltration for IgG4-related diseases: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) (2015) 0.77
Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodies. Auto Immun Highlights (2011) 0.77
Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol (2013) 0.77
Autoantibodies in autoimmune pancreatitis. Int J Rheumatol (2012) 0.77
An unusual case of autoimmune pancreatitis presenting as pancreatic mass and obstructive jaundice: a case report and review of the literature. J Med Case Rep (2011) 0.77
Acute pancreatitis: an emerging presentation for autoimmune pancreatitis in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2009) 0.76
An Unusual Presentation of Pediatric Autoimmune Pancreatitis. Pancreas (2016) 0.76
Imaging of focal autoimmune pancreatitis and differentiating it from pancreatic cancer. ISRN Radiol (2013) 0.76
Controversies in the management of primary sclerosing cholangitis. World J Hepatol (2016) 0.76
Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort. BMJ Open (2014) 0.75
Clinicopathological analysis of 12 patients with autoimmune pancreatitis. Exp Ther Med (2015) 0.75
Serum Concentrations of IgG4 in the Spanish Adult Population: Relationship with Age, Gender, and Atopy. PLoS One (2016) 0.75
Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Sci Rep (2016) 0.75
CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma: A Case Report and Review of the Literature. J Investig Med High Impact Case Rep (2015) 0.75
A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells. J Cytol (2013) 0.75
Steroid-responsive IgG4-related disease with isolated prostatic involvement: An unusual presentation with elevated serum PSA. Indian J Urol (2016) 0.75
The diagnostic challenges of autoimmune pancreatitis. Case Rep Gastroenterol (2015) 0.75
Autoimmune pancreatitis mimicking pancreatic tumor. J Surg Case Rep (2012) 0.75
Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis. World J Gastroenterol (2014) 0.75
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
IgG4-Seronegative Autoimmune Pancreatitis and Sclerosing Cholangitis. Case Rep Gastrointest Med (2015) 0.75
Autoimmune pancreatitis and cholangitis. World J Gastrointest Pharmacol Ther (2015) 0.75
Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease. Clin Exp Immunol (2016) 0.75
Autoimmune pancreatitis. Gland Surg (2016) 0.75
Recent advances in understanding and managing IgG4-related disease. F1000Res (2017) 0.75
A non-invasive screening technique for type 1 autoimmune pancreatitis. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
IgG4-unrelated type 1 autoimmune pancreatitis. World J Gastroenterol (2015) 0.75
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract (2017) 0.75
Testing for Anti-PBP Antibody Is Not Useful in Diagnosing Autoimmune Pancreatitis. Am J Gastroenterol (2016) 0.75
Deciphering autoimmune pancreatitis, a great mimicker: case report and review of the literature. Case Rep Gastrointest Med (2015) 0.75
Recent advances in autoimmune pancreatitis. Gastroenterol Hepatol (N Y) (2008) 0.75
Clinical and Immunopathologic Profile of Mexican Patients with IgG4 Autoimmune Pancreatitis. ISRN Rheumatol (2012) 0.75
Histological evaluation of obliterative phlebitis for the diagnosis of autoimmune pancreatitis. J Gastroenterol (2013) 0.75
IgG4-related intrahepatic sclerosing cholangitis resulting in sepsis caused by secondary suppurative inflammation: report of a case. Surg Today (2012) 0.75
A case of obstructive jaundice due to autoimmune pancreatitis and a review of the literature. Wien Med Wochenschr (2014) 0.75
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol (2013) 5.96
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc (2007) 3.59
Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol (2003) 3.36
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol (2008) 3.15
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol (2007) 3.14
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol (2007) 2.82
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg (2008) 2.66
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis (2002) 2.41
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35
ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointest Endosc (2006) 2.30
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol (2011) 2.17
EUS-guided biliary drainage for patients with malignant biliary obstruction with an indwelling duodenal stent (with videos). Gastrointest Endosc (2012) 2.15
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14